[Determination of gamma-glutamyltransferase in patients with chronic anti-epileptic, neuroleptic and anti-parkinsonism therapy].
D000410:Alanine Transaminase / Q000378:metabolism; D000927:Anticonvulsants / Q000009:adverse effects*; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000378:metabolism; D006801:Humans; D008297:Male; D014149:Tranquilizing Agents / Q000009:adverse effects*; D005723:gamma-Glutamyltransferase / Q000378:metabolism*
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D014149:Tranquilizing Agents; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Dosaggio della gamma GT in pazienti in terapia cronica con farmaci antiepilettici, neurolettici maggiori ed antiparkinsoniani.